Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
The randomized CONNECT trial found Dexcom G7 lowered A1C by 1.6% on average and improved time in range by five hours a day.
- On Saturday, June 6, researchers presented results from the CONNECT randomized controlled trial at the American Diabetes Association's 2026 Scientific Sessions in New Orleans, demonstrating Dexcom G7 significantly improves glucose control for Type 2 diabetes patients not using insulin.
- The CONNECT study evaluated 283 adults across 22 primary care practices to assess whether continuous glucose monitoring improves outcomes versus routine care over 26 weeks.
- Participants using Dexcom G7 experienced an average 1.6% A1C reduction at 26 weeks, representing a 0.9% greater reduction than the control group, while achieving five hours more daily time in the target glucose range.
- Dr. Roy Beck, medical director of the JAEB Center for Health Research, stated, "The CONNECT study is the first level A evidence," demonstrating strong benefit for the non-insulin using population.
- A 6-month extension phase of the trial is currently underway, aiming to provide further data on the sustainability of CGM benefits up to 12 months.
12 Articles
12 Articles
CGM ‘substantially’ improves glycemia for adults with type 2 diabetes not using insulin
NEW ORLEANS — Continuous glucose monitoring may have a role for adults with type 2 diabetes who are not using insulin, according to results from the CONNECT trial.“We know that CGM has been shown to be effective for individuals with any type of diabetes using insulin, but the data for the effectiveness of CGM for individuals with type 2 diabetes not on insulin is not as robust,”
Dexcom’s glucose monitor use shows benefit in non-insulin diabetic patients in study - Regional Media News
By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients with type 2 diabetes not using insulin, compared with routine care, according to study results. The results were presented on Saturday at the American Diabetes Association. Here are more details from the study: • The 26-week study tested 283 non-insulin using diabetic patients, of whom ha…
Dexcom CONNECT Study: The Most Significant Clinical Study ...
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
